Skip to main content
Premium Trial:

Request an Annual Quote

Randox: Qnostics SARS-CoV-2 Molecular Controls

Randox has launched whole pathogen molecular controls for SARS-CoV-2. The controls were developed by UK scientists and are being made available by Randox under the Qnostics brand name. The controls are for use to ensure accurate coronavirus test and system performance and are manufactured using whole pathogens to mimic the patient sample. The controls contain the entire SARS-COV-2 genome, incuding conserved regions recommended by the US Centers for Disease Control and Prevention and the World Health Organization, and they are compatible for use with commercial and in-house testing methods. 

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.